HemoNIRS: a Paradigm Shift in the Process of Musculoskeletal Rehabilitation of ACL Injuries in Cyclic Sports Athletes.
HemoNIRS: Un Cambio De Paradigma En El Proceso De Rehabilitación Musculoesquelética De Lesiones De Ligamento Cruzado Anterior Mediante Dispositivos NIRS En Deportistas Que Realizan Deportes Cíclicos
1 other identifier
observational
129
0 countries
N/A
Brief Summary
Muscle haemodynamics has so far been assessed using at most 2-3 near-infrared spectroscopy devices on isolated muscles and without correlating variables. At the same time, research on musculoskeletal pathologies is limited, and there are no studies that analyse the haemodynamic changes that occur when the anterior cruciate ligament (ACL) is injured and whether these changes last over time. The aim of the study is to monitor and evaluate the physiological changes produced by ACL injury on muscle performance using non-invasive near-infrared spectroscopy (NIRS) devices in trained athletes. This descriptive cross-sectional observational multicentre multicentre study, with Balearic Islands ethics committee IB 5585/24PI, will include males aged 18-65 years who have undergone ACL surgery, divided into 3 groups that: have an evolution of less than 6 months (ACL1), more than 2 years since the surgical intervention and are already practising normal physical-sports activities (ACL2) and the control group (CON) that has never suffered an ACL affectation to date. The 3 groups will perform an incremental intervallic test (4:1) on a cycloergometer or treadmill (according to the specificity of their sport), where different muscular haemodynamic variables will be assessed using 12-24 NIRS devices. The main study variables will be the muscular haemodynamic values of each muscle analysed and their correlation between them: muscular oxygen saturation, absolute capillary haemoglobin, loaded and unloaded with oxygen and relative muscular haemoglobin blood flow, loaded and unloaded with oxygen. Secondary variables will be heart rate, socio-demographic variables (age, toxic habits, injury and sports history) and subjective perception of effort (RPE-20).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2024
CompletedFirst Posted
Study publicly available on registry
October 1, 2024
CompletedStudy Start
First participant enrolled
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2026
ExpectedOctober 1, 2024
September 1, 2024
12 months
September 25, 2024
September 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Muscular Oxygen Saturation (SmO2 - %)
Percentage of haemoglobin + myoglobin at muscle capillary level loaded with oxygen
From the start of the test up to 3 minutes after the end of the test
Absolute Capillary Haemoglobin (ThB - g/dL)
grams of haemoglobin + myoglobin loaded and unloaded with oxygen divided by decilitres of blood taken up by the devices in the muscle capillaries
From the start of the test up to 3 minutes after the end of the test
Oxygen-loaded capillary haemoglobin (O2HHb - g/dL)
grams of haemoglobin + oxygen-loaded myoglobin divided by the decilitres of blood taken up by the devices in the muscle capillaries
From the start of the test up to 3 minutes after the end of the test
Capillary Haemoglobin Oxygen Depleted (HHb - g/dL)
grams of haemoglobin + oxygen-loaded myoglobin divided by the decilitres of blood taken up by the devices in the muscle capillaries
From the start of the test up to 3 minutes after the end of the test
Blood Flow of Relative Muscle Haemoglobin (ThBBF - g/dL/min)
relative value of haemoglobin blood flow per unit time circulating in the muscle capillary when heart rate values are added.
From the start of the test up to 3 minutes after the end of the test
Blood Flow of Oxygen Loaded Relative Muscle Haemoglobin (O2HHbBF - g/dL/min)
Relative value of oxygen-loaded haemoglobin blood flow per unit time circulating in the muscle capillary when heart rate values are added.
From the start of the test up to 3 minutes after the end of the test
Blood Flow of Oxygen Discharged Relative Muscle Haemoglobin (HHbBF - g/dL/min)
Relative value of the blood flow of oxygen discharged haemoglobin per unit time circulating in the muscle capillary when heart rate values are added.
From the start of the test up to 3 minutes after the end of the test
Secondary Outcomes (6)
Heart Rate (ppm)
From the start of the test up to 3 minutes after the end of the test
Subjective perception of effort (RPE-20)
From the start of the test up to 3 minutes after the end of the test. At the end of each quarter minute of test work, during the one minute rest period, the patient will be asked his or her RPE.
Anthropometry and adiposity indicators: height
The following variables will only be recorded once, at the beginning of the study, mainly to check that the eligibility criteria are met and to determine at a descriptive statistical level the normality and homogeneity of the sample.
Anthropometry and adiposity indicators: weight
The following variables will only be recorded once, at the beginning of the study, mainly to check that the eligibility criteria are met and to determine at a descriptive statistical level the normality and homogeneity of the sample.
Anthropometry and adiposity indicators: skinfolds
The following variables will only be recorded once, at the beginning of the study, mainly to check that the eligibility criteria are met and to determine at a descriptive statistical level the normality and homogeneity of the sample.
- +1 more secondary outcomes
Study Arms (3)
LCA1
Patients with ACL involvement (with less than 6 months of evolution since the surgical intervention (IQ)) and are in a phase in which they can perform the incremental intervallic test either on a cycloergometer or treadmill.
LCA2
Patients who have recovered from an ACL injury for more than 2 years. And can perform the incremental intervallic test either on a cycloergometer or treadmill.
CON
Patients who have never suffered an ACL injury or involvement to date. And can also perform the test.
Interventions
An incremental interval test of 4\' of work for 1\' of rest will be performed at an individual intensity below the aerobic threshold. At the end of the rest minute, the load shall be increased slightly. In order to be as adjusted and individualised as possible, the subjective physical condition level stated by the patient during the sociodemographic data collection shall be taken as a reference for the establishment of the initial load, being a value of power (W) in cycle ergometer and speed (km/h) in treadmill. Never less than 50W or 6 km/h, respectively. The minimum incremental values will be 25W or 0.5km/h until you are unable to complete a full interval. An incomplete interval shall also be recorded and analysed. During the one minute rest period, as will have been well emphasised during the explanation of the test, no part of the body may be moved at all, so at the end of the 4 minutes of work, the evaluator will count down for the patient to get ready and remain stil
Eligibility Criteria
The sample, which will be selected by convenience, will be made up of participants who have a diagnosis of ACL involvement and who have undergone surgery (total or partial), either recently or have had an injury in previous years, may be recruited to participate in the study. Healthy, physically active patients who have never had an ACL injury will also be recruited. The sample will initially come from the Físic Espai de Salut Integral, Centre Re3MOVE, MET Salut, Hospital Universitari Son Espases (HUSE) and San Juan de Déu Palma-Inca centres. Other private and public physiotherapy, rehabilitation and recovery centres, as well as private entities (clubs, federations, associations and organisations) that may contain participants susceptible to being included in the study, are expected to be included as they are accepted by the respective research commissions.
You may qualify if:
- Men aged 18 to 65
- An adipose layer of \<2 cm in areas of NIRS placement, assessed with a plicometer
- Understand written, read and spoken Spanish, English or Catalan.
You may not qualify if:
- Having any cardio-metabolic, hormonal, neurological or other comorbidities that could affect participation in the study (e.g. severe mental illness, end-stage disease).
- Eligibility criteria (LCA1 group)
- Regular athlete with training and/or competition \>3 days/wk prior to injury.
- ACL injury \<6 months after surgery.
- Able to perform an incremental intervallic test on a cycloergometer or treadmill.
- Eligibility criteria (LCA2 group)
- Regular athlete with training and/or competition \>3 days a week.
- ACL injury \>2 years after surgery.
- Able to perform an incremental intervallic test on a cycloergometer or treadmill.
- Eligibility criteria (CON group)
- Regular athlete with training and/or competition \>3 days a week.
- Never suffered an ACL injury in any knee - Able to perform incremental intervallic test on cycleergometer or treadmill.
- \- Incapacitating pain that prevents assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Francesc Valenzuela-Pascual, PhD
Universitat de Lleida
- STUDY DIRECTOR
Oriol Martínez-Navarro, PhD
Universitat de Lleida
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student and Associate Professor
Study Record Dates
First Submitted
September 25, 2024
First Posted
October 1, 2024
Study Start
December 2, 2024
Primary Completion
November 30, 2025
Study Completion (Estimated)
December 2, 2026
Last Updated
October 1, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ICF